These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The response of human lymphoma cells in vitro to bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea. Drewinko B; Novak JK; Barranco SC Cancer Res; 1972 Jun; 32(6):1206-8. PubMed ID: 4113143 [No Abstract] [Full Text] [Related]
9. Treatment of malignant brain tumors with nitrosoureas. Hansen HH; Muggia FM Cancer Chemother Rep; 1971 Apr; 55(2):99-100. PubMed ID: 4330275 [No Abstract] [Full Text] [Related]
11. Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors. Kinne DW; Humphrey EW Cancer Chemother Rep; 1972 Feb; 56(1):53-9. PubMed ID: 5030809 [No Abstract] [Full Text] [Related]
12. 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer. van Eden EB; Falkson HC; Falkson G Cancer Chemother Rep; 1970 Oct; 54(5):347-59. PubMed ID: 5514624 [No Abstract] [Full Text] [Related]
13. BCNU (1,3,bis(B-chloroethyl)-1-nitrosourea. Effects on advanced Hodgkin's disease and other neoplasia. Lessner HE Cancer; 1968 Aug; 22(2):451-6. PubMed ID: 4873194 [No Abstract] [Full Text] [Related]
14. A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer. Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG Cancer Res; 1972 Jun; 32(6):1278-9. PubMed ID: 4113144 [No Abstract] [Full Text] [Related]
15. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4]. Brunner KW; Maurice P; Sonntag RW Schweiz Med Wochenschr; 1972 Oct; 102(43):1546-51. PubMed ID: 4647016 [No Abstract] [Full Text] [Related]
16. Topical lomustine in the treatment of psoriasis. Peck GL; Guss SB; Key DJ Arch Dermatol; 1972 Aug; 106(2):172-6. PubMed ID: 4558698 [No Abstract] [Full Text] [Related]
17. Lack of correlation between clinical and angiographic findings in patients with brain tumors under BCNU chemotherapy. Koo AH; Fewer D; Wilson CB; Newton TH J Neurosurg; 1972 Jul; 37(1):9-14. PubMed ID: 4338690 [No Abstract] [Full Text] [Related]
18. Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil. Shapiro WR J Natl Cancer Inst; 1971 Feb; 46(2):359-68. PubMed ID: 4256014 [No Abstract] [Full Text] [Related]
19. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors. Wilson CB; Boldrey EB; Enot KJ Cancer Chemother Rep; 1970 Aug; 54(4):273-81. PubMed ID: 4334089 [No Abstract] [Full Text] [Related]
20. Effect of chemotherapy and-or head irradiation on survival of mice with intracranial glioma. Thomson JM; Maruyama Y; Schwartz S; Hahn E Radiology; 1971 Oct; 101(1):187-94. PubMed ID: 4329540 [No Abstract] [Full Text] [Related] [Next] [New Search]